Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038619
Filing Date
2025-08-07
Accepted
2025-08-07 08:36:25
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prme-20250630.htm   iXBRL 10-Q 1041825
2 EX-10.1 q2202510-qex101.htm EX-10.1 18330
3 EX-10.2 q2202510-qex102.htm EX-10.2 74938
4 EX-10.3 q2202510-qex103.htm EX-10.3 51429
5 EX-10.4 q2202510-qex104.htm EX-10.4 103345
6 EX-10.5 q2202510-qex105.htm EX-10.5 77328
7 EX-10.6 q2202510-qex106.htm EX-10.6 113516
8 EX-31.1 q2202510-qex311.htm EX-31.1 11743
9 EX-32.1 q2202510-qex321.htm EX-32.1 7342
  Complete submission text file 0001628280-25-038619.txt   6312626

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20250630.xsd EX-101.SCH 39672
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prme-20250630_cal.xml EX-101.CAL 64924
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prme-20250630_def.xml EX-101.DEF 229460
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20250630_lab.xml EX-101.LAB 553996
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20250630_pre.xml EX-101.PRE 390948
70 EXTRACTED XBRL INSTANCE DOCUMENT prme-20250630_htm.xml XML 754980
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)